ArticleFrontiers in neuroscience2025
Frontal-subcortical dysfunction in toxic oil syndrome: a proof-of-concept eye-tracking and cognitive study four decades after exposure.
Article in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Digital eye tracking and plasma biomarkers: Distinguishing functional cognitive impairment from Alzheimer's disease biology.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Toxic Oil Syndrome (TOS) emerged in Spain in 1981 after ingestion of rapeseed oil adulterated with aniline derivatives. More than four decades later, survivors continue to report cognitive complaints, but objective evidence of long-term dysfunction remains limited. Methods: In this case-control study, 47 TOS survivors and 44 matched healthy controls completed validated eye-tracking paradigms (visually guided, memory-guided, and antisaccade tasks) and a standardized neuropsychological battery. Groups did not differ significantly in age, sex, or education. Results: TOS survivors showed preserved performance on visually guided and memory-guided saccades, with no group differences in latency, gain, peak velocity, or spatial error (all Conclusion: Findings indicate persistent frontal-subcortical circuit dysfunction in TOS survivors, consistent with immune- or vascular-mediated injury patterns rather than progressive neurodegeneration. Eye-tracking provides a noninvasive biomarker of latent executive dysfunction and may be useful for long-term monitoring of populations exposed to environmental toxins.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.